Patients with acquired pure red cell aplasia respond to PI3Kδ inhibitor rapidly
Am J Hematol
.
2024 Apr 12.
doi: 10.1002/ajh.27325.
Online ahead of print.
Authors
Zhenzhen Wang
1
,
Bo Jiang
1
,
Lin Song
1
,
Mingyuan Sun
1
,
Chunhong Li
1
,
Xiaoxia Li
1
,
Weiwei Zheng
1
,
Yuan Tao
1
,
Qi Sun
1
,
Junyuan Qi
1
Affiliation
1
State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
PMID:
38607227
DOI:
10.1002/ajh.27325
No abstract available
Publication types
Letter
Grants and funding
NCRC-1-020/National Clinical Research Center for Blood Disease of China
Y-HR2022ZD-0774/Chinese Society of Clinical Oncology, Beijing Xisike Clinical Oncology Research Foundation